Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · 42 citations · 19 references
MedicineMicrobiologyPharmacologyAntimicrobial ResistanceMolecular PharmacologyStructure-activity RelationshipsAntibacterial PharmacologyAntibiotic ResistanceAntimicrobial Drug InteractionsEnzyme InhibitionMolecular ModelingStructure-activity Relationship AnalysisAntibiotic Mechanisms Of ActionCarbonic Anhydrase InhibitorsEnzyme-inhibitor BindingHomologyInhibition ConstantsInhibitor Binding AffinityInhibitor SelectivityStructure-activity Relationship Modeling
Vancomycin-resistant enterococci (VRE), consisting of pathogenic Enterococcus faecalis and E. faecium, is a leading cause of hospital-acquired infections (HAIs). We recently repurposed the FDA-approved human carbonic anhydrase (CA) inhibitor acetazolamide (AZM) against VRE agent with the likely mechanism of action for the molecules being inhibition of one, or both, of the bacterial CA isoforms expressed in VRE. To elucidate how inhibitor binding to the enzymes relates to MIC, we further characterised the inhibition constants (Ki) against the E. faecium α-CA (Efα-CA) and γ-CA (Efγ-CA), as well as against human CA I (hCAI) and human CA II (hCAII) to assess selectivity. We have also utilised homology modelling and molecular dynamics (MD) simulations to gain a better understanding of the potential interactions the molecules are making with the targets. In this paper, we elaborate on the SAR for the AZM analogs as it pertains to MIC and Ki for each CA.
19
Alicia Hidrón, Jonathan R. Edwards, Jean B. Patel et al. · Infection Control and Hospital Epidemiology · 2008 · 3.8K citations
Dawn Sievert, Philip Ricks, Jonathan R. Edwards et al. · Infection Control and Hospital Epidemiology · 2012 · 1.6K citations
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17
James M. Sherman · Bacteriological Reviews · 1937 · 181 citations · Full text
Isao Nishimori, Tomoko Minakuchi, Kaori Morimoto et al. · Journal of Medicinal Chemistry · 2006 · 167 citations · Full text